Eye floaters are dots or specks in a persons vision that seem to float away when the person tries to look directly at them. They are made up of the vitreous of the eye, and in most cases, they are completely normal. The vitreous is the clear, gel-like substance that fills out most of the eye.
Eye floaters do not usually require treatment, as they themselves do not cause any harm to the sight. However, in some cases, eye floaters may make it difficult to see and will require removal to restore sight.
Eye floaters may also be an early sign of an underlying issue, such as damage to the retina.
Eye floaters are a natural phenomenon due to the vitreous body of the eye. The vitreous helps give the eye its round shape.
Floaters occur when this vitreous body starts to shrink. As it shrinks, little fibers can break away and become stringy. This is what doctors call vitreous detachment.
This detachment causes stringy masses of vitreous that can disrupt light coming into the retina. This casts a tiny shadow into the eye, which is what makes floaters noticeable.
Eye floaters are a normal part of the aging process. The American Society of Retina Specialists note that conditions such as vitreous detachment, which causes more floaters, are more common after the age of 60.
Everyone can get eye floaters at some point, though most people ignore them. Many may only notice them when they look at a blank, bright surface or area such as the sky.
Although they can be distracting at first, most eye floaters tend to settle down to the bottom of the eye, beneath the field of vision.
However, the American Society of Retina Specialists recommend that a person who notices sudden symptoms such as floaters get checkups with an ophthalmologist within the first few months after the symptoms appear, to check for any signs of more serious issues.
Although some floaters in the eye may be a normal part of the aging process, experiencing a sudden increase of floaters in the eye may be a sign of another issue, such as retinal detachment.
When retinal detachment occurs, it is not uncommon for people to experience other symptoms along with eye floaters. They may experience flashes of light that are not there, especially in the side of their fields of vision. They may also experience a loss of vision in the sides of their eyes.
Retinal detachment is serious and may lead to blindness without treatment. Anyone who notices a sudden and noticeable increase in floaters, along with other symptoms, should see an eye doctor immediately.
There are also more serious causes of floaters in the eye, including:
Anyone who notices a sudden increase in eye floaters should see an eye doctor to obtain a complete diagnosis.
The main symptoms of eye floaters are small areas in a persons field of vision that seem out of place.
Floaters can take different shapes, including:
They may also appear as a dark or lighter area of vision. Sometimes, the area where the floater is will look slightly blurry compared with the rest of the field of vision.
Floaters are tiny but can significantly affect the vision, as they are very close to the input of the eye.
One characteristic of eye floaters is that they seem to dart back and forth across the field of vision. Trying to look directly at a floater will cause it to move away in the direction the person looks.
When the person rests their eyes, the floaters seem to drift on their own.
Although it may not be possible to prevent eye floaters, it is still helpful to follow some basic practices to keep the eyes healthy. These include:
Eye floaters do not require treatment in most cases.
Although floaters may be irritating when a person notices them, they do not pose any direct threat to the sight.
In most cases, floaters settle down to the bottom of the eye, beneath the field of vision. The Columbia University Department of Ophthalmology estimate that it can take up to 3 months for a persons first floater to completely detach.
In rare circumstances, floaters may become very dense and potentially disrupt a persons vision. In these cases, a doctor may recommend a procedure called a vitrectomy.
During a vitrectomy, a healthcare professional will surgically remove the vitreous gel causing the floater. They will then replace this vitreous gel with a saline solution, or a bubble filled with gas or oil. Most people notice no difference between the vitreous and the saline solution after surgery.
Doctors generally reserve this procedure for serious circumstances, as it comes with its own set of potentially serious complications. These include cataracts and retinal detachment.
There are some alternatives to surgery for removing floaters.
A laser treatment method called laser vitreolysis may break apart or dissolve larger floaters, making them less noticeable. However, laser therapy is not for everyone.
An ophthalmologist will need to do a complete diagnosis in each case to see if the person could benefit from laser therapy.
Many people will experience eye floaters at one point or another. They can be annoying but are often harmless. Eventually, they may settle outside the field of vision, and most do not require treatment.
In very rare circumstances, eye floaters may disrupt vision and require surgical treatment. A sudden, very noticeable increase in eye floaters may also be a sign of other serious issues, such as retinal detachment, which could lead to blindness if a person does not receive prompt medical treatment.
Anyone who notices a sudden increase in eye floaters should visit an eye doctor for a full diagnosis.
Continued here:
Eye floaters: What causes them, and what can you do? - Medical News Today
- Eye exercises for vertigo: Exercises to try at home - Medical News Today - January 6th, 2023
- EMDR therapy: Everything you need to know - Medical News Today - December 28th, 2022
- Eye care professional - Wikipedia - December 28th, 2022
- New gene therapy to treat rare eye disease now available in Alberta ... - December 28th, 2022
- Novaliq submits New Drug Application seeking approval for first-of-a-kind Dry Eye Disease Treatment CyclASol - PR Newswire - August 11th, 2022
- New research digs into the genetic drivers of heart failure, with an eye to precision treatments - STAT - August 11th, 2022
- Gamma Probe Device Market Trends, On-going Demand, Opportunities, Segmentation, and Forecast till 2031 - BioSpace - August 11th, 2022
- Babies born exposed to opioids and drugs need our support - GoErie.com - August 3rd, 2022
- Centrifuge Market: Increasing Prevalence of Infectious Diseases to Drive the Market - BioSpace - August 3rd, 2022
- Myopic macular degeneration: What it is, and more - Medical News Today - July 17th, 2022
- Roche Wraps Week with a Bang, Touting Long-Term Breast Cancer, AMD Data - BioSpace - July 17th, 2022
- EyePoint Pharmaceuticals Announces Positive 12-Month Safety and Efficacy Data from Phase 1 DAVIO Clinical Trial Evaluating EYP-1901 for the Treatment... - July 17th, 2022
- What Are These Things Floating in Front of My Eyes? - The Epoch Times - July 17th, 2022
- Adverum Biotechnologies Presents Best-Corrected Visual Acuity and Central Subfield Thickness Analyses After a Single IVT Injection of ADVM-022... - July 17th, 2022
- Retinoblastoma among children: Early detection and treatment are vital - The Financial Express - May 20th, 2022
- Perceive Biotherapeutics Appoints Anne E. Fung MD, as Chief Medical Officer to Drive Transformational Clinical Programs - PR Newswire - May 20th, 2022
- Qlaris Bio Reports Phase 2 Clinical Trial Results Demonstrating Favorable Safety and Tolerability Profile and Positive Efficacy Signal for QLS-101 -... - May 20th, 2022
- How the Pandemic is Taking a Toll on Rhode Island's Front-Line Health Care Workers - Rhode Island Monthly - May 20th, 2022
- Myrtelle Enters into a Worldwide Exclusive License Agreement with Rescue Hearing to Develop and Commercialize Gene Therapy for the Treatment of... - May 20th, 2022
- Capsida, Adverum, Instil and Metagenomi Showcase Therapies at ASGCT - BioSpace - May 20th, 2022
- GenSight Biologics Announces Publication of a Study of the Impact of LHON Disease on the Lives of Patients and Relatives in Journal of... - May 20th, 2022
- How Diabetes can be a driver for High blood pressure and eventually leads to Hypertension - APN News - May 20th, 2022
- Daewoong Pharmaceutical and HanAll Biopharma Invest in Turn Biotechnologies to Expand Growth Initiative - Yahoo Finance - April 11th, 2022
- Christian group prepares legal challenge over conversion therapy ban - The Telegraph - April 11th, 2022
- PFE: 5 Global Healthcare Stocks to Buy as BofA Warns of a - StockNews.com - April 11th, 2022
- Adverum Biotechnologies Proceeds with IND Amendment for ADVM-022 Phase 2 Trial in Wet AMD After Receiving Requested Type C Meeting Feedback from the... - April 11th, 2022